Nantahala Capital Management, LLC 13D and 13G filings for Syndax Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:46 pm Sale | 2022-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Nantahala Capital Management, LLC | 975,705 1.400% | -2,074,854 (-68.02%) | Filing |
| 2022-02-14 08:34 am Purchase | 2021-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Nantahala Capital Management, LLC | 3,050,559 5.800% | 3,050,559 (New Position) | Filing |